Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Urticaria”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableStudy completedNCT01059526
What this trial is testing

Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire 81
Very early researchEnded earlyNCT01694381
What this trial is testing

Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

Who this might be right for
Acute Ischemic Stroke
TSI, LLC 8
Not applicableStudy completedNCT02620254
What this trial is testing

Mast Cell Connect: A Registry for Patients With Mastocytosis

Who this might be right for
Mastocytosis
Blueprint Medicines Corporation 743
Testing effectiveness (Phase 2)UnknownNCT01036659
What this trial is testing

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Who this might be right for
Angioedema
Bernstein, Jonathan A., M.D. 50
Large-scale testing (Phase 3)Study completedNCT02023164
What this trial is testing

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Who this might be right for
Acute Urticaria
JDP Therapeutics, Inc. 36
Testing effectiveness (Phase 2)Study completedNCT04618211
What this trial is testing

Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaHereditary Angioedema Type IHereditary Angioedema Type II+7 more
Pharvaris Netherlands B.V. 74
Large-scale testing (Phase 3)WithdrawnNCT01253382
What this trial is testing

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shire
Large-scale testing (Phase 3)Study completedNCT04654351
What this trial is testing

Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 2
Large-scale testing (Phase 3)Study completedNCT00292981
What this trial is testing

C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study)

Who this might be right for
Hereditary Angioedema
CSL Behring 57
Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Large-scale testing (Phase 3)Study completedNCT00456508
What this trial is testing

Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 147
Testing effectiveness (Phase 2)UnknownNCT04489160
What this trial is testing

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

Who this might be right for
Traumatic Brain InjuryTrauma, Head
Leiden University Medical Center 106
Large-scale testing (Phase 3)Study completedNCT00368823
What this trial is testing

A Trial of Point of Care Information in Ambulatory Pediatrics

Who this might be right for
Acute Otitis MediaAllergic RhinitisSinusitis+5 more
University of Washington 44
Large-scale testing (Phase 3)Study completedNCT00262301
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic EdemaGenetic Disorders
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Large-scale testing (Phase 3)Looking for participantsNCT06361537
What this trial is testing

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Who this might be right for
Acute Hereditary Angio Edema
Octapharma 124
Large-scale testing (Phase 3)Looking for participantsNCT06819774
What this trial is testing

Phase III Clinical Study of Cetirizine Hydrochloride Injection in Treatment of Acute Urticaria

Who this might be right for
Acute Urticaria
Shandong New Time Pharmaceutical Co., LTD 284
Early research (Phase 1)Study completedNCT02024152
What this trial is testing

Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg

Who this might be right for
Acute Urticaria
JDP Therapeutics, Inc. 24
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Next Page